Vasoactive intestinal peptide stimulates prolactin mRNA expression in turkey pituitary cells: Effects of dopaminergic drugs

Proceedings of the Society for Experimental Biology and Medicine

Volumn 212, Issue 1, 1996, Pages 52-62

  Xu, M ^a   Proudman, J A ^b   Pitts, G R ^a   Wong, E A ^c   Foster, D N ^a   El Halawani, M E ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE; DOPAMINE 1 RECEPTOR; MESSENGER RNA; PROLACTIN; QUINPIROLE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ARTICLE; DRUG EFFECT; DRUG RECEPTOR BINDING; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HYPOPHYSIS CELL; NONHUMAN; PROLACTIN RELEASE; PROLACTIN SYNTHESIS; RECEPTOR UPREGULATION; TRANSCRIPTION REGULATION; TURKEY (BIRD);

EID: 0029962439     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-212-43991     Document Type: Article

References (60)

1. Said SI, Mutt V. Polypeptide with broad biological activity: Isolation from the small intestine. Science 169:1217-1218, 1970.
2. Rotsztejn WH, Bensson J, Beraud G, Bluet-Pajot MT, Kordon C, Rosselin G, Duval J. Effect of vasoactive intestinal peptide (VIP) on the release of andnohypophysial hormones from purified cells obtained by unit gravitysedimentation: Inhibition by dexamethasone of VIP-induced prolactin release. Neuroendocrinology 31:282-286, 1990.
3. Nicosia S, Spada A, Giannattasio G. Effect of vasoactive intestinal polypeptide on the pituitary gland. In: Said SI, Ed. Vasoactive Intestinal Peptide. New York: Raven Press, pp263-275, 1982.
4. Vijayan E, Samson WK, Said SI, McCann SM. Vasoactive intestinal polypeptide: Evidence for a hypothalamic site of action to release growth hormone, luteinizing hormone and prolactin in conscious ovariectomized rats. Endocrinology 104:53-57, 1979.
5. Frawley LS, Neill JD. Stimulation of prolactin secretion in Rhesus monkeys by vasoactive intestinal polypeptide. Neuroendocrinology 33:79-83, 1981.
6. Enjalbert A, Arancibia S, Ruberg M, Blue-Pajot MT, Rotsztejn WH, Kordon C. Stimulation of in vitro prolactin release by vasoactive intestinal peptide. Neuroendocrinology 31:200-204, 1980.
7. Samson WK, Said SI, Snyder G, McCann SM. In vitro stimulation of prolactin release by vasoactive intestinal peptide. Peptides 1:325-332, 1980.
8. Matsushita N, Kato Y, Shimatsu A, Katakami H, Yanaihara H, Imura H. Effects of VIP, TRH, GABA, and dopamine on prolactin release from superfused rat anterior pituitary cells. Life Sci 32:1263-1269, 1983.
9. Shimatsu A, Kato Y, Ohta H, Tojo K, Kabayama Y, Inoue T, Yanaihara N, Imura H. Involvement of hypothalamic vasoactive intestinal polypeptide (VIP) in prolactin secretion induced by serotonin in rats. Proc Soc Exp Biol Med 175:414-416, 1984.
10. Abe H, Engler D, Molitch ME, Bollinger-Gruber J, Reichlin S. Vasoactive intestinal peptide is a physiological mediator of prolactin release in the rat. Endocrinology 116:1383-1390, 1985.
11. Kaji H, Chihara K, Abe H, Kita T, Kashio Y, Okimura Y, Fujita T. Effect of passive immunization with antisera to vasoactive intestinal peptide and peptide histidine isoleucine amide on 5-hydroxy-L-tryptophan induced prolactin release in rats. Endocrinology 117:1914-1919, 1985.
12. Ohta H, Kato Y, Shimatsu A, Tojo K, Kabayama Y, Inoue T, Yanachara N, Imura H. Inhibition by antiserum to vasoactive intestinal polypeptide (VIP) of prolactin secretion induced by serotonin in the rat. Eur J Pharmacol 109:409-412, 1985.
13. Proudman JA, Opel H. Stimulation of prolactin secretion from turkey anterior pituitary cells in culture. Proc Soc Exp Biol Med 187:448-454, 1988.
14. Opel H, Proudman JA. Stimulation of prolactin release in turkeys by vasoactive intestinal peptide. Proc Soc Exp Biol Med 187:455-460, 1988.
15. El Halawani ME, Silsby JL, Mauro LJ. Vasoactive intestinal peptide is a hypothalamic prolactin-releasing neuropeptide in the turkey (Meleagris gallopavo). Gen Comp Endocrinol 78:66-73, 1990.
16. El Halawani ME, Silsby JL, Mauro LJ. Enhanced vasoactive intestinal peptide-induced prolactin secretion from anterior pituitary cells of incubating turkeys (Meleagris gallopavo). Gen Comp Endocrinol 80:138-145, 1990.
17. Youngren OM, Silsby JL, Rozenboim I, Phillips RE, El Halawani ME. Vasoactive intestinal peptide mediates prolactin secretion induced by electrical stimulation of the turkey hypothalamus. Gen Comp Endocrinol 95:330-336, 1994.
18. Pitts GR, Youngren OM, Silsby JL, Foster LK, Foster DN, Rozenboim I, Phillips RE, El Halawani ME. Role of vasoactive intestinal peptide in the control of prolactin-induced turkey incubation behavior. 1. Acute infusion of vasoactive intestinal peptide. Biol Reprod 50:1344-1349, 1994.
19. Mauro LJ, Elde RP, Youngren OM, Phillips RE, El Halawani ME. Alterations in hypothalamic vasoactive intestinal peptide-like immunoreactivity are associated with reproduction in the female turkey. Endocrinology 125:1795-1804, 1989.
20. Wong EA, Ferrin NH, Silsby JL, El Halawani ME. Cloning of a turkey prolactin cDNA: Expression of prolactin mRNA throughout the reproductive cycle of the domestic turkey (Meleagris gallopavo). Gen Comp Endocrinol 83:18-26, 1991.
21. Sharp PJ, Sterling RJ, Talbot RT, Huskisson NS. The role of hypothalamic vasoactive intestinal polypeptide in the maintenance of prolactin secretion in incubating bantam hens: Observations using passive immunization, radioimmunoassay and immunohistochemistry. J Endocrinol 22:5-13, 1989.
22. Talbot RT, Hanks MC, Sterling RJ, Sang HM, Sharp PJ. Pituitary prolactin messenger ribonucleic acid levels in incubating and laying hens: Effects of manipulating plasma levels of vasoactive intestinal polypeptide. Endocrinology 129:496-502, 1991.
23. El Halawani ME, Silsby JL, Rozenboim I, Pitts GR. Increased egg production by active immunization against vasoactive intestinal peptide in the turkey (Meleagris gallopavo). Biol Reprod 52:179-183, 1995.
24. Lamberts SWJ, Macleod RM. Regulation of prolactin secretion at the level of the lactotroph. Physiol Rev 70:279-218, 1990.
25. Macleod RM, Lehmeyer JE. Studies on the mechanisms of the dopamine-mediated inhibition of prolactin secretion. Endocrinology 94:1077-1085, 1974.
26. Von Werder K, Eversman T, Rjosk HK, Fahlbusch R. Treatment of hyperprolactemia. Froneiers Neuroendocrinology 7:123-159, 1982.
27. Levy A, Lightman SL. Quantitative in-situ hybridization histochemistry in the rat pituitary gland: Effect of bromocriptine on prolactin and pro-opiomelanocortin gene expression. J Endocrinol 118:205-210, 1988.
28. Carter DA, Chew LJ, Murphy D. In vitro regulation of rat prolactin mRNA poly(A) tail length: Modulation by bromocriptine. J Endocrinol 5:201-204, 1993.
29. Tong Y, Pelletier G. In vivo regulation of prolactin gene expression in the male rat: Role of sex steroids and dopamine. J Neuroendocrinol 3:635-639, 1991.
30. Maurer RA. Dopaminergic inhibition of prolactin synthesis and prolactin messenger RNA accumulation in cultured pituitary cells. J Biol Chem 255:8092-8097, 1980.
31. Maurer RA. Transcriptional regulation of the prolactin gene by ergocryptine and cyclic AMP. Nature 294:94-97, 1981.
32. Maurer RA. Adenosine 3′,5′-monophosphate derivatives increase prolactin synthesis and prolactin mRNA levels in ergocryptine-treated pituitary cells. Endocrinology 110:1957-1963, 1982.
33. Arey BJ, Burris TP, Basco P, Freeman ME. Infusion of dopamine at low concentrations stimulates the release of prolactin from α-methyl-p-tyrosine-treated rats. Proc Soc Exp Biol Med 203:60-63, 1993.
34. 2 receptor subtype mediates dopaminergic stimulation of prolactin secretion from the anterior pituitary gland. Neuroendocrinology 54:175-183, 1991.
35. Hill JB, Nagy GM, Frawley LS. Suckling unmasks the stimulatory effect of dopamine on prolactin release: Possible role for α-melanocyte-stimulating hormone as a mammotrope responsiveness factor. Endocrinology 129:843-547, 1991.
36. 2 dopamine receptor agonist, at low concentrations on prolactin release in female rats in vitro. Life Sci 51:727-732, 1992.
37. 2 dopamine receptor agonist, on secretion of prolactin as assessed by the reverse hemolytic plaque assay. Life Sci 53:304-313, 1993.
38. El Halawani ME, Burke WL. Role of catecholamines in photo-periodically-induced gonadal development in Coturnix quail. Biol Reprod 13:603-609, 1975.
39. El Halawani ME, Silsby JL, Fehrer SC, Behnke EJ. Inhibitory influence of catecholamines on prolactin release in the turkey. Gen Comp Endocrinol 54:339-343, 1984.
40. Harvey SA, Chadwick A, Border G, Scanes CG, Phillips JG. Neuroendocrine control of prolactin secretion. In: Scanes CG, Ottinger MA, Kenny AD, Balthazart J, Cronshaw J, Hones IC, Eds. Aspects of Avian Endocrinology: Practical and Theoretical Implications. Lubbock, TX: Texas Tech Press, pp41-64, 1982.
41. Fehrer SC. The role of monoamines and thyrotropin releasing hormone in prolactin and luteinizing hormone release by the pituitary gland of the young domeslid turkey. PhD Thesis, University of Minnesota, St. Paul, 1984.
42. Hall TR, Chadwick A. Hypothalamic control of prolactin and growth hormone secretion in the pituitary gland of the pigeon and the chicken: In vitro studies. Gen Comp Endocrinol 49:135-143, 1983.
43. Hall TR, Chadwick A. Dopaminergic inhibition of prolactin release from pituitary glands of the domestic fowl incubated in vitro. J Endocrinol 103:63-69, 1984.
44. El Halawani ME, Youngren OM, Silsby JL, Phillips RE. Involvement of dopamine in prolactin release induced by electrical stimulation of the hypothalamus of the female turkey (Meleagris gallopavo). Gen Comp Endocrinol 84:360-364, 1991.
45. Hopkins CR, Farquhar MG. Hormone secretion by cells dissociated from rat anterior pituitaries. J Cell Biol 59:276-303, 1973.
46. Fehrer SC, Silsby SL, Behnke EJ, El Halawani ME. Hypothalamic and serum factors influence on prolactin and luteinizing hormone release by the pituitary gland of the young turkey (Meleagris gallopavo). Gen Comp Endocrinol 59:73-81, 1985.
47. Proudman JA, Opel H. Turkey prolactin: Validation of a radioimmunoassay and measurement of changes associated with broodiness. Biol Reprod 25:573-580, 1981.
48. Chomczynski P, Sacchi N. Single step method RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biol 162:156-159, 1987.
49. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, pp7.43-7.45, 1989.
50. Shi L, Gast RT, Gopalraj M, Olszewski NE. Characterization of a shoot-specific, GA3-and ABA-regulated gene from tomato. Plant J 2:153-159, 1992.
51. El Halawani ME, Silsby JL, Mauro LJ. Vasoactive intestinal peptide (VIP) is a hypothalamic prolactin releasing neuropeptide in the turkey (Meleagris gallapavo). Gen Comp Endocrinol 78:66-73, 1990.
52. SAS Institute, Inc. SAS/STAT Users Guide, Version 6. Cary, NC: SAS Institute, Inc., 4th ed.
53. Rozenboim I, El Halawani ME. Characterization of vasoactive intestinal peptide pituitary membrane receptors in turkey hens during different stages of reproduction. Biol Reprod 48:1129-1134, 1993.
54. You S, Silsby JL, Farris J, Foster DN, El Halawani ME. Tissue-specific alternative splicing of turkey preprovasoactive intestinal peptide messenger ribonucleic acid, its regulation, and correlation with prolactin secretion. Endocrinology 136:2602-2610, 1995.
55. Arnaout MA, Garthwaite TL, Martinson DR, Hagen TC. Vasoactive intestinal polypeptide is synthesized in anterior pituitary tissue. Endocrinology 119:2052-2057, 1986.
56. Kasper S, Popescu RA, Torsello A, Vrontakis ME, Ikejiani C, Friesen HG. Tissue-specific regulation of vasoactive intestinal peptide messenger ribonucleic acid levels by estrogen in the rat. Endocrinology 130:1796-1801, 1992.
57. Nagy G, Mulchaney JJ, Neill JD. Autocrine control of prolactin secretion by vasoactive intestinal peptide. Endocrinology 122:364-366, 1988.
58. Haisenleder DJ, Ortolano GA, Landefeld TD, Zmeili SM, Marshall JC. Prolactin mRNA concentrations in 4-day cycling rats and during the prolactin surge. Endocrinology 124:2023-2028, 1989.
59. Creese I, Sibley DR, Leff SE. Agonist interactions with dopamine receptors: Focus on radioligand-binding studies. Fed Proc 43:2779, 1984.
60. O'Halloran DJ, Jones PM, Ghalei MA, Bloom SR. Rat anterior pituitary neuropeptides following chronic prolactin manipulation: A combined radioimmunoassay and mRNA study. J Endocrinol 131:411-419, 1991.